A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Clinical trial NCT05643885 · COMPLETED
Trial details
- NCT number
- NCT05643885
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-31
- Primary completion
- 2024-08-30
- Enrollment
- 7304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.